EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024

Jin-Wen Wu iD, Qi Lan iD, Ding-Shan Zhang iD, Yu-Hong Jian iD, Lin Yu iD, Rui Hao iD, Ping Liu iD, Gang Luo iD, Ming-Tai Chen iD, Meng-Nan Liu iD

Cardiovascular Therapeutics · 2025

DOI: 10.1155/cdr/5178894 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cardiovascular Therapeutics, 2025. Verfasst von Jin-Wen Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, Myocardial Infarction, Biomedical Research. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Southwest Medical University, Department of Science and Technology of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The NACHT, leucine‐rich repeat, and pyrin domain–containing protein 3 (NLRP3) inflammasome plays an essential role in myocardial infarction (MI) development. Up to now, no bibliometric analyses of NLRP3 in MI have been performed. Publications related to NLRP3 in MI from 1 January 2013 to 20 August 2024 were extracted from the Web of Science Core Collection (WoSCC). HistCite Pro, CiteSpace, VOSviewer, Scimago Graphica, and bibliometric online analysis program were used for bibliometric analysis and visualization. The impact of publications was assessed using the total global citation score (TGCS). A total of 324 articles (284 articles and 40 reviews) were included. China has published the most in this field, followed by the United States. Harbin Medical University was the leading institution for research related to NLRP3 in MI. Professor Abbate A. from the United States has made significant achievements in this field. International Immunopharmacology was the most active journal and Journal of Cardiovascular Pharmacology was the most cited journal. This study systematically summarizes the research results of NLRP3 in MI over the past 12 years. NLRP3 in myocardial ischemia–reperfusion injury (MIRI) will become a hot research topic, and translational research on NLRP3 inhibitors in MIRI will benefit a greater number of patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesMyocardial InfarctionBiomedical ResearchMyocardiumCardiologyHumansBibliometricsAnimalsPeriodicals as TopicSignal Transduction

Stichwörter der Autor:innen

NLRP3bibliometric analysismyocardial infarctionmyocardial ischemia–reperfusion injury

Substanzen

NLR Family, Pyrin Domain-Containing 3 ProteinInflammasomesNLRP3 protein, human

Autor:innen und Institutionen

  • Department of Cardiovascular Medicine, The Affiliated Traditional Chinese Medicine Hospital, Southwest Medical University, Luzhou, Sichuan, China.
  • Department of Orthopaedics, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, Chengdu, Sichuan, China.
  • School of Nursing, Southwest Medical University, Luzhou, Sichuan, China.
  • Department of Cardiovascular Disease, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China.

ORCID-Profile: Jin-Wen Wu, Qi Lan, Ding-Shan Zhang, Yu-Hong Jian, Lin Yu, Rui Hao, Ping Liu, Gang Luo, Ming-Tai Chen, Meng-Nan Liu

Förderung

  • Southwest Medical University
  • Department of Science and Technology of Sichuan Province

Zitieren

APA

Wu, J. W., Lan, Q., Zhang, D. S., Jian, Y. H., Yu, L., Hao, R., Liu, P., Luo, G., Chen, M. T., & Liu, M. N. (2025). Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024. Cardiovascular Therapeutics. https://doi.org/10.1155/cdr/5178894

Vancouver

Wu JW, Lan Q, Zhang DS, Jian YH, Yu L, Hao R, et al. Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024. Cardiovascular Therapeutics. 2025. doi:10.1155/cdr/5178894

BibTeX
@article{Wu2025,
  author = {Wu, Jin-Wen and Lan, Qi and Zhang, Ding-Shan and Jian, Yu-Hong and Yu, Lin and Hao, Rui and Liu, Ping and Luo, Gang and Chen, Ming-Tai and Liu, Meng-Nan},
  title = {Frontiers and Hotspot Evolution of NLRP3 Inflammasome in Myocardial Infarction Research: A Bibliometric Analysis From 2013 to 2024},
  journal = {Cardiovascular Therapeutics},
  year = {2025},
  doi = {10.1155/cdr/5178894}
}
Kostenlos starten →